Speciality: Hematology
Description:
A warm welcome to all the medical professionals to this highly anticipated panel discussion on "An Eagle's View - Evidence-based Discussion on Iron Deficiency Anemia." Following our in-depth look at IDA, this session offers a unique opportunity for a dynamic and interactive exchange among experts. The goal is to address the multifaceted challenges in diagnosing and treating IDA in various patient populations, from managing comorbidities to navigating treatment resistance.
This panel will delve into pressing questions that arise in clinical practice. Topics will include the most effective strategies for iron repletion in patients with chronic inflammatory conditions, such as inflammatory bowel disease, where oral iron absorption is often impaired. The experts will also discuss the optimal use of intravenous iron formulations, considering factors like dosing, patient safety, and the cost-benefit analysis in different healthcare settings. This discussion will highlight the importance of personalized, evidence-based decision-making.
Therefore, get an overall knowledge of how to apply an evidence-based approach to the complexities of iron deficiency anemia in a panel discussion format. Absorb the shared knowledge, get your questions answered by experts, and follow Hidoc for more such insightful webinar sessions.
See More Webinars @ Hidoc Webinars
1.
New guidelines for radiation therapy for HPV-associated head and neck cancer
2.
Review looks at potential treatment targets in the tumor microenvironment.
3.
Even when they are not paying attention, children are still learning.
4.
The Benefits of Exercise for Substance Use Disorders.
5.
The top three drugs for multiple myeloma treatment upfront are four.
1.
The New Era of Oncology: Key Updates and Clinical Insights
2.
Everything You Need to Know About RDW-CV: A Comprehensive Guide
3.
Decoding Granular Cell Tumor: What You Need to Know
4.
Subchorionic Hematoma: Causes, Symptoms, and Treatment
5.
HCC in Melanoma: Role of HCC Codes and Moderate Whole Body Hyperthermia
1.
International Lung Cancer Congress®
2.
Genito-Urinary Oncology Summit 2026
3.
Future NRG Oncology Meeting
4.
ISMB 2026 (Intelligent Systems for Molecular Biology)
5.
Annual International Congress on the Future of Breast Cancer East
1.
Recent Data Analysis for First-Line Treatment of ALK+ NSCLC: A Final Discussion
2.
An In-Depth Look At The Signs And Symptoms Of Lymphoma- The Conclusion
3.
Lorlatinib in the Management of 1st line ALK+ mNSCLC (CROWN TRIAL Update) - Conclusion
4.
Cost Burden/ Burden of Hospitalization For R/R ALL Patients
5.
Navigating the Complexities of Ph Negative ALL - Part XI
© Copyright 2025 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation